December 17, 2025 · Form 4 insider transaction
Kearns Evan sold 125,602 shares of Cogent Biosciences, Inc. at $39.45 per share, a transaction worth $4.95M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs.; Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.